Jefferies Group
AXDX icon

Jefferies Group’s Accelerate Diagnostics AXDX Stock Holding History

Jefferies Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,840
Closed -$1.36M – 2306
2018
Q4 		$1.36M Buy
+11,840
New +$1.75M 0.01% 1013
2015
Q4 		– Sell
-1,170
Closed -$189K – 2273
2015
Q3 		$189K Buy
+1,170
New +$253K ﹤0.01% 1944

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jefferies Group's AXDX Position: Q1 2019 in Review

Jefferies Group sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 1,060 shares — an estimated $122K sold.

Jefferies Group first reported a position in AXDX in Q4 2013 and held it in 3 quarters. The position peaked at $260K in Q4 2013. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

  • Jefferies Group reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Jefferies Group sold 1,060 Accelerate Diagnostics shares in Q1 2019, an estimated $122K.
  • Jefferies Group first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 3 quarters.
  • Jefferies Group's Accelerate Diagnostics position peaked at $260K in Q4 2013.
  • 114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.